A Study of Aleglitazar in Type 2 Diabetes Patients With Moderate Renal Impairment

NCT01043029 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

302

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus Type 2

Interventions

DRUG: aleglitazar
DRUG: pioglitazone

Sponsor

Hoffmann-La Roche